← Journal search
JOURNAL PROFILE
Download details (PDF) ↓

Immuno (ISSN 2673-5601) is an open-access journal published by MDPI in Switzerland. It covers Biochemistry, Genetics and Molecular Biology, Immunology and Microbiology and Medicine. It is indexed in Scopus, Web of Science, PubMed, DOAJ and HEC. Recorded metrics: impact factor 2.7, Scopus Q2, Web of Science Q3, CiteScore 4.1 and HEC X-Category. Article processing charge: USD 1,193. This profile brings together the journal's ISSN, publisher, country, subject area, HEC category, Scopus data, SJR and SCImago rank, Web of Science data, impact factor, indexing, open access status, APC, waiver policy, time to publication, aims and scope, about the journal, author instructions, journal website and registration details from the most reputable indexes, in one place.

Journal title

Immuno

ISSN
2673-5601
Subject area
BiochemistryGenetics and Molecular BiologyImmunology and MicrobiologyMedicineBiochemistry & Genetics and Molecular Biology (miscellaneous)Medicine (miscellaneous)Immunology
Indexed
ScopusWeb of SciencePubMedDOAJHEC
Scopus Quartile
Q2
WoS Quartile
Q3
Impact Factor
2.7
Country
Switzerland
Publisher
MDPI
SJR
0.708
Open access
Yes
APC (USD)
1193
About the journal
Immuno is a fully open-access journal published by MDPI AG (Switzerland). It has published all content under an open licence (CC BY) since 2021. Topics: innate immunity and inflammation, structural immunology, autoimmunity and immunoregulation, neuroimmunology, immunopathology and immunohistology, clinical/translational immunology.
Aims and Scope
Immuno provides a forum for basic and clinical investigations that advance understanding of immune processes, and publishes original research, reviews, conference reports, communications, and themed Special Issues. Its coverage ranges from adaptive and synthetic immune responses to immunogenetics and immunometabolism, infectious disease and vaccines, cancer and transplantation, developmental and reproductive immunology, and clinical applications; submissions are encouraged to provide sufficient methodological detail and supporting data for their findings to be assessed and reproduced.
SCImago Ranking
8131
HEC
X-Category
Journal Website
www.mdpi.com/journal/immuno ↗
Registered In
2021
Instructions for Authors URL
www.mdpi.com/journal/immuno/instructions ↗
Average Time To Publication After Submission (In Weeks)
7
APC Information URL
www.mdpi.com/journal/immuno/apc ↗
Waiver policy
Yes
Scopus URL
www.scopus.com/sourceid/21101196049 ↗
Scopus Cite Score
4.1
WoS Status
Emerging Sources Citation Index (ESCI)

Record last updated . Check current status at HEC HJRS, Scopus and the Web of Science Master Journal List before submitting. About our data.

Quick answers about Immuno

Is Immuno HEC recognised?

Yes. The catalogue records Immuno in HEC category X of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.

Is Immuno indexed in Scopus?

Yes. Immuno is listed as Scopus-indexed, in quartile Q2, with a CiteScore of 4.1. Check its current status on the Scopus Sources page.

Is Immuno in Web of Science?

Yes. Immuno is listed as a Web of Science journal in the Emerging Sources Citation Index (ESCI), with Web of Science quartile Q3. Confirm on Clarivate's Master Journal List.

What is the impact factor of Immuno?

The recorded journal impact factor of Immuno is 2.7. Clarivate updates impact factors every year in Journal Citation Reports.

Is Immuno open access, and what does it charge?

Immuno is an open-access journal and its APC is USD 1,193. Fees change, so check the journal's website before you submit.

How long does Immuno take to publish?

The recorded average time from submission to publication is about 7 weeks. Individual papers can take longer, especially when revisions are requested.

Who publishes Immuno?

Immuno is published by MDPI in Switzerland, under ISSN 2673-5601.

Research profile

Main research topics: Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, T-cell and B-cell Immunology, Immune Response and Inflammation, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies.

Source: OpenAlex (CC0), retrieved 20 November 2026. Counts cover works OpenAlex has indexed and differ from Scopus and Web of Science.

Browse similar journals

Find Journal